Science ❯ Biotechnology

Drug Research

Clinical Trials Investigational Drugs Targeted Therapies Oncology Nanobodies Liver Health Clinical Applications Clinical Research Clinical Studies AI in Drug Development

Pfizer Tops Q4 Estimates but Posts Loss on $4.4 Billion Charge, Reaffirms 2026 Outlook

Management reiterates a flat 2026 outlook centered on cost cuts, obesity programs, pivotal trials.

Insilico, Qilu Strike Near-$120 Million AI Drug Discovery Pact for Cardiometabolic Therapies

Eli Lilly to Acquire Ventyx Biosciences for $1.2 Billion in Bet on Oral NLRP3 Drugs

European Commission Authorizes Gobivaz, First Simponi Biosimilar, Across the EEA

Novo Nordisk to Acquire Akero for Up to $5.2 Billion to Expand in MASH